Jazz Pharmaceuticals
JAZZ
#2275
Rank
S$8.90 B
Marketcap
$144.27
Share price
-0.48%
Change (1 day)
-21.08%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.91

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.84. In 2022 the company made an earnings per share (EPS) of -$4.61 an increase over its 2021 EPS that were of -$7.01.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.91-58.52%
2022-$4.61-34.2%
2021-$7.01-224.83%
2020$5.61-53.25%
2019$12.0123.59%
2018$9.72-8.24%
2017$10.5923.74%
2016$8.5622.12%
2015$7.01478.49%
2014$1.21-74.93%
2013$4.83-27.11%
2012$6.6369.1%
2011$3.92245.98%
2010$1.13-462.5%
2009-$0.31-96.7%
2008-$9.48-27.04%
2007-$13.0065.47%
2006-$7.85-4.59%
2005-$8.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.24 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.80-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.87-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.61 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel